Skip to main content
. 2022 Apr 12;14(8):1932. doi: 10.3390/cancers14081932

Figure 1.

Figure 1

Study design. Schematic representation of fecal sampling for pediatric patients undergoing HSCT, in relation to the development of FN. Circles indicate the sampling timepoints, i.e., at baseline (before transplant; PRE), at the onset of neutropenia (day −2/+2; P2), at the onset of fever (day +4/+5; P5), at engraftment (TAKE) and after engraftment (day +20/+30; P20). Patients were stratified based on the median of total fever days into two groups: (i) less than or equal to three days (n = 16) and (ii) more than three days (n = 21).